MT

Michael Tousey

CEO

ImmunityBio

Breckenridge, Colorado


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
ImmunityBio
Industry
research
Employees
590.0
Seniority
C suite
Annual Revenue
14750000.0

Technologies

Gmail Google Apps Microsoft Azure Hosting Microsoft Office 365 Outlook Amazon AWS accessiBe WP Engine Hubspot Salesforce DoubleClick Google Maps Vimeo Google Maps (Non Paid Users) Linkedin Marketing Solutions Facebook Login (Connect) Google Tag Manager Google Analytics Facebook Custom Audiences Workday Recruit Google Dynamic Remarketing Google Font API New Relic Bootstrap Framework WordPress.org Mobile Friendly Facebook Widget Bing Ads Typekit DoubleClick Conversion Remote AI SAP Android SharePoint Python Flutter IoT Micro Viewpoint

Keywords

immunotherapy cancer infectious diseases natural killer t cell vaccines oncology vaccine fusion proteins clinical trials manufacturing covid19 yeast cell therapy biotechnology life sciences biotechnology: biological products (no diagnostic substances) health care biotechnology research cancer vaccines nk cells il-15 superagonist anktiva bladder cancer glioblastoma hiv treatment lynch syndrome non-small cell lung cancer natural killer cells dendritic cells memory t cells biological therapies checkpoint inhibitors car-t therapy immune response activation trial investigators patients research approach oncology solutions personalized medicine immuno-oncology cancer treatment innovation vaccine development phase 3 trials fda breakthrough therapy tumor-associated neoepitopes cancer prevention inclusion in clinical trials safety & efficacy experimental therapies molecular targeting cytotoxicity therapeutic vaccines co-therapy strategies serum biomarkers safe & effective treatments biotech research immune system boosters rare cancer types research partnerships patient advocacy long-term survival bioanalytical testing cell line licensing clinical research trials innovative treatments cancer treatment advanced therapies t-cell therapies hpv vaccines neoepitope prediction patient-centric approach biopharmaceuticals immune system enhancement combination therapies compassionate use programs fda-authorized therapies immune disorders market demand research & development healthcare professionals cancer patients caregivers investors hospital & health care health wellness & fitness mechanical or industrial engineering

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans